Print issue
Current | Past
The physician who helped establish Brazil's policy on the rights of people with disabilities now fights to rehabilitate Covid-19 patients
ANVISA authorizes the use of three COVID-19 drugs, but they are expensive and designed only for specific situations
A rare syndrome linked to the novel coronavirus causes lesions in multiple organs
Brazil is still behind in monitoring Sars-CoV-2 genetics, but an injection of funding for research networks and the acquisition of materials could improve the situation
